-
<![CDATA[Dual Orexin Receptor Agonists Show Lower Real-World Abuse Potential Than Traditional Insomnia Treatments]]>
11 Sep 2025 10:12 GMT
… using data from the FDA Adverse Event Reporting System … (22.3%), z-drugs (15.3%), ramelteon (8.0%), and … compared with other drugs for insomnia treatment. This observation included … the abuse potential of medications for the treatment of insomnia. Presented …
-
Idorsia highlights very low real-world abuse potential of DORA class for insomnia treatment at WSC 2025
08 Sep 2025 15:45 GMT
… with other drugs for insomnia treatment. This observation … and non-scheduled drugs (trazodone, doxepin, ramelteon). Trazodone was … Switzerland – a European biotech hub – Idorsia has … amp; Media Relations
Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, …
-
Efficacy of Dexmedetomidine as an Adjuvant to Ropivacaine for Intercostal Nerve Block in Elderly Patients Undergoing Video-Assisted Thoracoscopic Esophagectomy: A randomized Double-Blinded Trial
11 Aug 2025 18:22 GMT
… 21 Currently, randomized controlled trials (RCTs) are being … :2 mg, Nanjing Zhengdatianqing Pharmaceutical Co., Ltd., China; … surgery versus thoracotomy for treatment of patients with pulmonary … K, Tsubosa Y. Ramelteon and suvorexant for postoperative …
-
Enveric’s Patent Win Targets New Frontiers in Sleep Medicine
03 Jun 2025 22:14 GMT
… . The Cambridge-based biotech firm announced this week … of this pathway:
• Ramelteon (Rozerem®), a selective MT1… depressive disorders where conventional antidepressants often fall short … are clear. Sleep medicine intersects multiple market verticals …
-
Jay Glazer and Wife Rosie Glazer Offer Candid Look at ADHD and Relationships in New Qelbree® Content Series with Supernus Pharmaceuticals
29 May 2025 12:30 GMT
… treatment or when the dose is changed. Tell your doctor … should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and … of prescription drugs to the FDA. Visit www.fda.gov… About Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals is a …
-
Busy Philipps Empowers Women with ADHD to Go from Feeling Misrepresented to Being ‘Ms. Represented’ in First-of-its-Kind Campaign with Supernus Pharmaceuticals
20 May 2025 12:30 GMT
… treatment or when the dose is changed. Tell your doctor … avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and … prescription drugs to the FDA. Visit www.fda.gov… About Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals is a …
-
<![CDATA[DORAs Carry Lower Real-World Abuse, New Phase 3 Argus Data, RAP-219 Meets Primary End Point]]>
13 Sep 2025 15:40 GMT
… among several different classes of medications for insomnia, dual orexin … doxepin (22.3%), z-drugs (15.3%), ramelteon (8.0%), and DORAs … (OLE). In total, 139 treatment-emergent adverse events (TEAEs) were … initiate 2 phase 3 pivotal trials of RAP-219 in …
-
Onfi interactions: Alcohol, medications, and other factors
17 Mar 2025 16:02 GMT
… drugs that may interact with Onfi:
zolpidem (Ambien)
eszopiclone (Lunesta)
ramelteon (Rozerem … )
zaleplon (Sonata)
doxepin
suvorexant (Belsomra)
Steps you or your doctor … the right treatment option if you have certain medical conditions or …
-
Insufficient Evidence to Recommend Shu Mian Capsule in Managing Depression With or Without Comorbid Insomnia: A Systematic Review With Meta-Analysis and Trial Sequential Analysis
30 Jan 2025 14:32 GMT
… Alternative Medicine (CAM), including herbal remedies, over … Manufacturer: DaLong Pharmaceutical Co., Ltd.; FDA Approval No. Z20000105 … FDA-approved for depression treatment.28 While some antidepressant trials … psychiatric drugs as standard care. No trial …
-
Lunesta interactions: Alcohol, medications, and other factors
27 Jan 2025 19:59 GMT
… from the Food and Drug Administration (FDA). For details, see … )
ramelteon (Rozerem)
suvorexant (Belsomra)
trazodone
Steps you or your doctor may … right treatment option if you have certain medical conditions … t been enough clinical trials to determine whether …
About
© 1995-2025